Drugs / FluLaval® TF
last change Feb 2009 re-read 3 minutes ago

FluLaval® TF

Vaccine

Developed for
influenza
Investigated by
GlaxoSmithKline

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00727428 Aug 2008 influenza GlaxoSmithKline Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as FluLaval TF ClinicalTrials.gov intervention name — accepted as the source's own label NCT00727428 ↗
Modality Vaccine “the FluLaval TF influenza vaccine” NCT00727428 ↗
Route Intramuscular “One IM injection.” NCT00727428 ↗